DRD5 and neoplasm: Activation of DRD5 by the selective agonist SKF83959 upregulates reactive oxygen species (ROS) levels in tumor cells, thereby activating the mitochondrial apoptosis pathway while inhibiting the mTOR pathway to induce autophagic cell death (28).